GENERATION AND CHARACTERIZATION OF GENETIC REASSORTANTS BETWEEN POTENTIALLY PANDEMIC VIRUSES (A/H9N2 OR A/H5N8) AND THE A/HONG KONG/1/68/162/35 (H3N2) MASTER DONOR VIRUS

Código QR

GENERATION AND CHARACTERIZATION OF GENETIC REASSORTANTS BETWEEN POTENTIALLY PANDEMIC VIRUSES (A/H9N2 OR A/H5N8) AND THE A/HONG KONG/1/68/162/35 (H3N2) MASTER DONOR VIRUS

.

Guardado en:

Detalles Bibliográficos
Autores principales:	V. I. Grishchenko, M. V. Potapchuk, A. V. Fadeev, L. M. Tsybalova
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/acd70d66cfe844f79d61aaf8ed3cfe83
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Seasonality of influenza A(H3N2) virus: a Hong Kong perspective (1997-2006).
por: Julian W Tang, et al.
Publicado: (2008)

North American Triple Reassortant and Eurasian H1N1 Swine Influenza Viruses Do Not Readily Reassort to Generate a 2009 Pandemic H1N1-Like Virus
por: Wenjun Ma, et al.
Publicado: (2014)

Genetic Characterization and Pathogenesis of Three Novel Reassortant H5N2 Viruses in South Korea, 2018
por: Anh Thi Viet Nguyen, et al.
Publicado: (2021)

Reassortant Influenza A(H1N1)pdm09 Virus in Elderly Woman, Denmark, January 2021
por: Jakob N. Nissen, et al.
Publicado: (2021)

Epidemiology of the Influenza A Virus H5N1 Subtype and Memory of Immunity to the H2N2 Subtype
por: Masanori Terajima, et al.
Publicado: (2012)

Transcriptomic Characterization of the Novel Avian-Origin Influenza A (H7N9) Virus: Specific Host Response and Responses Intermediate between Avian (H5N1 and H7N7) and Human (H3N2) Viruses and Implications for Treatment Options
por: Laurence Josset, et al.
Publicado: (2014)

Intraspecies and interspecies transmission of mink H9N2 influenza virus
por: Zhao Yong-feng, et al.
Publicado: (2017)

Working Safely with H5N1 Viruses
por: Adolfo García-Sastre
Publicado: (2012)

CYTOPATHOGENICITY OF INFLUENZA VIRUS (H4 N3)
por: H. M. I. AL-HYALI
Publicado: (2021)

COMPARISON OF INFLUENZA A(H1N1)pdm09 GENOMES OBTAINED FROM DIFFERENT TYPES OF VIRUS-CONTAINING MATERIAL
por: A. V. Fadeev, et al.
Publicado: (2017)

Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses
por: Jiao Hu, et al.
Publicado: (2021)

Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice.
por: Bastian Hatesuer, et al.
Publicado: (2013)

Vacuna para virus influenza H5N1
por: Calvo A,Mario
Publicado: (2008)

Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States.
por: Martha I Nelson, et al.
Publicado: (2008)

Cooperating H3N2 Influenza Virus Variants Are Not Detectable in Primary Clinical Samples
por: Katherine S. Xue, et al.
Publicado: (2018)

Structural and antigenic variation among diverse clade 2 H5N1 viruses.
por: David A Shore, et al.
Publicado: (2013)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
por: I. V. Losev, et al.
Publicado: (2017)

Susceptibility of influenza A(H1N1)/pdm2009, seasonal A(H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014
por: Shan-shan Liu, et al.
Publicado: (2017)

Characterization of changes in the hemagglutinin that accompanied the emergence of H3N2/1968 pandemic influenza viruses.
por: Johanna West, et al.
Publicado: (2021)

A statistical analysis of antigenic similarity among influenza A (H3N2) viruses
por: Emmanuel S. Adabor
Publicado: (2021)

Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.
por: Misako Nakayama, et al.
Publicado: (2013)

The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
por: Cuiling Xu, et al.
Publicado: (2011)

Pathogenicity of the Novel A/H7N9 Influenza Virus in Mice
por: Chris Ka Pun Mok, et al.
Publicado: (2013)

The 2009 H1N1 Pandemic Influenza Virus: What Next?
por: David M. Morens, et al.
Publicado: (2010)

MOLE AND SPREADING OF AVIAN INFLUENZA VIRUS H5N1 IN THE WORLD
por: E. .. Mindolina
Publicado: (2012)

Emergencia de los virus Influenza A (H1N1)
por: Massoc P,Alejandra
Publicado: (2009)

HETEROSUBTYPIC IMMUNE RESPONSE AND CROSS-PROTECTION AGAINST A HIGHLY PATHOGENIC A (H5N1) INFLUENZA VIRUS IN MICE IMMUNIZED WITH COLD-ADAPTED A/LENINGRAD/134/17/57 (H2N2) INFLUENZA VIRUS
por: A. R. Rekstin, et al.
Publicado: (2014)

Compromiso miocárdico en infección grave por virus influenza H1N1
por: Morales V,Gonzalo, et al.
Publicado: (2011)

Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses
por: Wenshuai Wang, et al.
Publicado: (2016)

Antiviral Gene Expression in Young and Aged Murine Lung during H1N1 and H3N2
por: Rebecca Harris, et al.
Publicado: (2021)

Glycan remodeled erythrocytes facilitate antigenic characterization of recent A/H3N2 influenza viruses
por: Frederik Broszeit, et al.
Publicado: (2021)

Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility
por: Sigrid Gouma, et al.
Publicado: (2020)

Evidence of infection by H5N2 highly pathogenic avian influenza viruses in healthy wild waterfowl.
por: Nicolas Gaidet, et al.
Publicado: (2008)

Features 2016–2018 current human influenza A(H3N2) viruses circulating in Russia
por: P. A. Petrova, et al.
Publicado: (2020)

POPULATION IMMUNITY TO INFLUENZA VIRUS A(H1N1)pdm09, A(H3N2) AND B IN THE ADULT POPULATION OF THE RUSSIAN FEDERATION LONG-TERM RESEARCH RESULTS
por: O. S. Konshina, et al.
Publicado: (2017)

Cobalt-catalyzed electrooxidative C-H/N-H [4+2] annulation with ethylene or ethyne
por: Shan Tang, et al.
Publicado: (2018)

Isolation, sequencing and phylogenetic analysis of the hemagglutinin, neuraminidase and nucleoprotein genes of the Chilean equine influenza virus subtypes H7N7 and H3N8
por: Müller,Ilse, et al.
Publicado: (2005)

Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
por: Irina Isakova-Sivak, et al.
Publicado: (2014)

Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus.
por: Philippe Buchy, et al.
Publicado: (2010)

Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward
por: Anthony S. Fauci
Publicado: (2012)